Clin2
NCT07375498Possibly a fitNot yet recruiting

Safety study of a liposome rescue drug in healthy adults

Healthy AdultOverdose Antidote

This early-stage study tests a new liposomal medicine given as a one-time rescue treatment in healthy adults. Participation helps researchers understand how safe the drug is and how the body processes it, which is a first step toward future use in patients.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
12 people
Ages
18 years to 35 years
Study type
Interventional

Who can take part

  • You must be between 18 and 30 years old.
  • You must be in good general health with no long-term medical conditions.
  • You must have a body mass index (BMI) between 18.5 and 30.
  • You must not have donated blood or lost a significant amount of blood in the last 6 months.
  • You must test negative for hepatitis B, hepatitis C, syphilis, and HIV.
  • You must be willing to use effective birth control during the study.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07752069Not yet recruiting· Phase 1
Testing different versions of an experimental medicine in healthy people

This trial compares how well different forms of an experimental drug are absorbed by the body. Healthy volunteers will receive the drug and have blood tests to see which version works best.

Beijing, Beijing Municipality
NCT07829406Not yet recruiting· Phase 1
Safety study of a new medicine in healthy adults

This study tests a new medicine in healthy people to see if it is safe and how the body handles it. Participating could help understand side effects before testing in patients.

Salt Lake City, Utah
NCT07162441Recruiting· Phase 1
Drug interaction study in healthy volunteers

This trial tests two experimental drugs in healthy adults to see how they interact with each other and to check their safety. It involves taking the drugs in a specific order over multiple days.

Seoul, Gwanak-gu
NCT07722299Not yet recruiting· Phase 1
Safety study of SAL0167 in healthy adults

This study tests a new medication called SAL0167, which may help lower cholesterol, in healthy volunteers. It is a first-in-human study, meaning it looks at safety and how your body handles the drug, so it may not directly benefit your health but helps in developing a potential treatment for high cholesterol.

Guangzhou, Guangdong
NCT06867406Not yet recruiting· Phase 1
Safety study of a new tablet in healthy adults

This trial tests a new tablet drug in healthy people to see how safe it is and how the body processes it. It is an early-stage study, meaning it helps find the right dose and check for side effects.

Beijing, Beijing Municipality
NCT06904807Recruiting· Phase 1
Safety study of LIFE-001 in healthy volunteers

This trial tests a new drug called LIFE-001 in healthy volunteers to check its safety and how the body handles it. It is for people without significant health issues.

Bayswater, Victoria

Hear when a new Healthy Adult trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.